These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8125833)

  • 21. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococci.
    Schlegel L; Sissia G; Fremaux A; Geslin P
    J Antimicrob Chemother; 1997 Jan; 39(1):95-8. PubMed ID: 9044034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyphenolic Secondary Metabolites Synergize the Activity of Commercial Antibiotics against Clinical Isolates of β-Lactamase-producing Klebsiella pneumoniae.
    Dey D; Ghosh S; Ray R; Hazra B
    Phytother Res; 2016 Feb; 30(2):272-82. PubMed ID: 26668123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.
    Hallander HO; Dornbusch K; Gezelius L; Jacobson K; Karlsson I
    Antimicrob Agents Chemother; 1982 Nov; 22(5):743-52. PubMed ID: 7181485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bactericidal effect of beta-lactams and amikacin alone or in association against Klebsiella pneumoniae producing extended spectrum beta-lactamase.
    Roussel-Delvallez M; Sirot D; Berrouane Y; Goffart M; Gourde B; Wallet F; Courcol RJ
    J Antimicrob Chemother; 1995 Jul; 36(1):241-6. PubMed ID: 8537274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant prevention concentrations of ciprofloxacin against urinary isolates of Escherichia coli and Klebsiella pneumoniae.
    Daoud Z; Sokhn ES; Azar E; Masri K; Doron S
    J Infect Dev Ctries; 2014 Feb; 8(2):154-9. PubMed ID: 24518624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The postantibiotic effect induced by antimicrobial combinations.
    Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
    Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
    Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
    Valdes JM; Baltch AL; Smith RP; Hammer MC; Ritz WJ
    J Antimicrob Chemother; 1990 Apr; 25(4):575-84. PubMed ID: 2112539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro susceptibility of Escherichia coli and Klebsiella sp. to antibiotics].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1990 Apr; 43(4):659-69. PubMed ID: 2199690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synergic effects of quinolones and oral cephem antibiotics on Serratia marcescens.
    Otsuki M; Nishino T
    J Antimicrob Chemother; 1996 Nov; 38(5):771-6. PubMed ID: 8961046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
    Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in-vitro capillary model.
    Zinner SH; Dudley MN
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():49-54. PubMed ID: 3100491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
    Aracil-García B; Oteo-Iglesias J; Cuevas-Lobato Ó; Lara-Fuella N; Pérez-Grajera I; Fernández-Romero S; Pérez-Vázquez M; Campos J;
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):480-486. PubMed ID: 27469416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of various oral antibacterial agents against extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
    Nakamura T; Komatsu M; Yamasaki K; Fukuda S; Higuchi T; Ono T; Nishio H; Sueyoshi N; Kida K; Satoh K; Toda H; Toyokawa M; Nishi I; Sakamoto M; Akagi M; Mizutani T; Nakai I; Kofuku T; Orita T; Zikimoto T; Natsume S; Wada Y
    J Infect Chemother; 2014 Jan; 20(1):48-51. PubMed ID: 24462425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of the antiseptic polyhexanide against gram-negative bacteria.
    Fabry WH; Kock HJ; Vahlensieck W
    Microb Drug Resist; 2014 Apr; 20(2):138-43. PubMed ID: 24192397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silver nanoparticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae.
    Panáček A; Smékalová M; Večeřová R; Bogdanová K; Röderová M; Kolář M; Kilianová M; Hradilová Š; Froning JP; Havrdová M; Prucek R; Zbořil R; Kvítek L
    Colloids Surf B Biointerfaces; 2016 Jun; 142():392-399. PubMed ID: 26970828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
    Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
    J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.